The CNBC headline this morning — "Hedge funds are betting big on industrials in 2026" — is exactly the kind of consensus signal that makes contrarian alarm bells ring. Let me show you why the crowded trade is about to unwind. CAT: Insider Exodus Meets Tariff Euphoria According to platform insider data, Caterpillar executives executed 100 insider transactions totaling $326.36M in February alone, with Group President Bob De Lange dumping 9,055 shares across multiple tranches on 2026-02-10. This is not routine rebalancing. When a C-suite executive sells in a sustained pattern during a sector that hedge funds are just now rotating into, that's a leading indicator of deteriorating fundamentals. The data shows CAT's net income collapsed year-over-year: Q2025Q3 produced $2.3B NI, but Q2025Q4 saw that drop to $2.4B, while revenue stalled at $19.1B (vs. $17.1B a year prior). The margin picture is worse: NI/REV declined from 13.4% to 12.5% — not the expansion you'd expect from a capex supercycle. Meanwhile, debt sits at $30.7B against $10.0B cash. Tariff optimism is pricing in steady margins. The data says they're already compressing. DE (Deere): The Leverage Story Nobody's Talking About John Deere's balance sheet is stretched: $61.0B in debt against $8.3B in cash (a 7.3x ratio), with assets of $106.0B. Q2025Q4 revenue was $12.4B and NI was $1.1B — a 8.9% margin that's barely held constant. But here's the setup the industrials bulls are missing: If tariff uncertainty persists (and the Trump administration's own tariff reversal signals it will), capex cycles compress *faster* than revenue. Deere's OCF is only $7.5B against $61B in debt obligations. That's a refinancing squeeze waiting to happen — especially if farm commodity prices roll over. The company is trading on *hope* that tariffs boost infrastructure spending. The balance sheet doesn't have room for error. LLY: The Obesity Drug Pen Masking the Real Problem Eli Lilly just launched its Zepbound pen with a month's worth of doses — a convenience play designed to drive volume. The market is cheering. Breakout Beth on the forum is already sounding the alarm on margin compression, and she's right, but the data tells an even starker story. Q2025Q4 shows $19.3B revenue and $6.6B NI — a 34.2% margin. But look at the trend: Q2024Q4 was $13.5

Research these companies